A rising number of cancer patients are being prescribed ivermectin instead of undergoing chemotherapy, a new report has found.
A report published by the JAMA Network found that ivermectin prescriptions for cancer patients doubled between January and July 2025. Researchers also found that white southern males were most likely to take the drug.